CorDynamics
CorDynamics is a leading cardiovascular contract research organization dedicated to drug discovery, safety pharmacology, and toxicology studies. They offer tailored study designs, industry expertise, and advanced models to investigate heart failure, pulmonary arterial hypertension, atrial fibrillation, thrombosis, ischemia/reperfusion, and other cardiovascular conditions. Their facilities are GLP and OECD compliant, equipped for state-of-the-art assessments, and they collaborate with clients to address pressing cardiovascular questions with quick turnaround times and regulatory compliance.
Industries
Nr. of Employees
small (1-50)
CorDynamics
2242 W. Harrison St. Chicago, IL 60612-3552
Services
Regulatory‑oriented preclinical safety studies assessing QT interval, heart rate, blood pressure, ECG and comprehensive cardiac function using telemetry, anesthetized and isolated heart models under GLP/OECD‑aligned procedures.
Customizable discovery studies and disease models for heart failure, pulmonary arterial hypertension, atrial fibrillation, thrombosis and ischemia/reperfusion to support lead optimization and preclinical efficacy evaluation.
Advisory services including protocol development, data review and interpretation, external monitoring and regulatory risk assessments to support program de‑risking and development planning.
Delivery of study datasets and preparation support for scientific presentations, posters and downloadable study reports to facilitate client and collaborator communications.
Regulatory‑oriented preclinical safety studies assessing QT interval, heart rate, blood pressure, ECG and comprehensive cardiac function using telemetry, anesthetized and isolated heart models under GLP/OECD‑aligned procedures.
Customizable discovery studies and disease models for heart failure, pulmonary arterial hypertension, atrial fibrillation, thrombosis and ischemia/reperfusion to support lead optimization and preclinical efficacy evaluation.
Advisory services including protocol development, data review and interpretation, external monitoring and regulatory risk assessments to support program de‑risking and development planning.
Delivery of study datasets and preparation support for scientific presentations, posters and downloadable study reports to facilitate client and collaborator communications.
Expertise Areas
- Cardiovascular safety pharmacology (preclinical)
- Preclinical cardiovascular disease modeling and discovery
- Telemetry and conscious animal physiological monitoring
- Cardiac electrophysiology and arrhythmia modeling
Key Technologies
- Telemetry physiological recording systems
- Isolated perfused heart (Langendorff) preparations
- Echocardiography with strain analysis
- Pressure‑volume loop acquisition and analysis
News & Updates
Orlando, FL, March 16-20, 2025
Beverly Hills, CA, March 19-21, 2025
Utrecht, Netherlands, October 13-15, 2025
New Orleans, LA, November 8-10, 2025
Phoenix, AZ, November 16-19, 2025
Presented at the 2025 Society of Toxicology Meeting in Orlando, Florida.
Orlando, FL, March 16-20, 2025
Beverly Hills, CA, March 19-21, 2025
Utrecht, Netherlands, October 13-15, 2025
New Orleans, LA, November 8-10, 2025
Phoenix, AZ, November 16-19, 2025
Presented at the 2025 Society of Toxicology Meeting in Orlando, Florida.